-
Something wrong with this record ?
Kardiovaskulární riziko a inhibice cyklooxygenázy. Soustavný přehled popisných studií selektivních a neselektivních inhibitorů cyklooxygenázy 2 [Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cycloogygenase 2]
Patricia McGettigan, David Henry
Language Czech Country Czech Republic
Document type Meta-Analysis, Randomized Controlled Trial
- MeSH
- Anti-Inflammatory Agents, Non-Steroidal adverse effects MeSH
- Risk Assessment MeSH
- Cyclooxygenase Inhibitors adverse effects MeSH
- Cardiovascular Diseases chemically induced MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Meta-Analysis MeSH
- Randomized Controlled Trial MeSH
Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cycloogygenase 2
Kardiovaskulární riziko a inhibice cyklooxygenázy. Soustavný přehled popisných studií selektivních a neselektivních inhibitorů cyklooxygenázy 2 = Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cycloogygenase 2 /
Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cycloogygenase 2 /
Lit. 44
- 000
- 00000naa a2200000 a 4500
- 001
- bmc07011268
- 003
- CZ-PrNML
- 005
- 20111210104125.0
- 008
- 071005s2007 xr u cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a McGettigan, Patricia $4 aut
- 245 10
- $a Kardiovaskulární riziko a inhibice cyklooxygenázy. Soustavný přehled popisných studií selektivních a neselektivních inhibitorů cyklooxygenázy 2 = $b Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cycloogygenase 2 / $c Patricia McGettigan, David Henry
- 246 11
- $a Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cycloogygenase 2
- 314 __
- $a Discipline of Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, Newcastle, AU
- 504 __
- $a Lit. 44
- 650 _2
- $a inhibitory cyklooxygenasy $x škodlivé účinky $7 D016861
- 650 _2
- $a kardiovaskulární nemoci $x chemicky indukované $7 D002318
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a antiflogistika nesteroidní $x škodlivé účinky $7 D000894
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Henry, David $4 aut
- 773 0_
- $w MED00011025 $t JAMA $g Roč. 15, č. 1 (2007), s. 59-71 $x 1210-4132
- 910 __
- $a ABA008 $b B 1805 $c 1156
- 990 __
- $a 20071011
- 991 __
- $a 20071229
- BAS __
- $a 3
- BMC __
- $a 2007 $b Roč. 15 $c č. 1 $d s. 59-71 $i 1210-4132 $m JAMA (České a slovenské vyd.) $x MED00011025
